Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Genzyme to Resubmit LemtradaTM Application for FDA Review
Age-dependent effects on the treatment response of natalizumab in MS patients.
Guillain-Barré syndrome in Colombia: where do we stand now?
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
PLEGRIDY™ (peginterferon beta-1a) two-year data confirm maintenance of efficacy and safety in multiple sclerosis patients
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
Characterization of human platelet binding of recombinant T cell receptor ligand.
Systematic approaches to central nervous system myelin.
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
The risk of Bipolar Disorders in Multiple Sclerosis.
Pages
« first
‹ previous
…
163
164
165
166
167
168
169
170
171
…
next ›
last »